Panayi, Marios C. http://orcid.org/0000-0003-2635-5638
Boerner, Thomas
Jahans-Price, Thomas
Huber, Anna
Sprengel, Rolf http://orcid.org/0000-0003-3370-0970
Gilmour, Gary
Sanderson, David J. http://orcid.org/0000-0002-3560-5507
Harrison, Paul J. http://orcid.org/0000-0002-6719-1126
Walton, Mark E. http://orcid.org/0000-0003-0117-2894
Bannerman, David M. http://orcid.org/0000-0002-3024-7595
Funding for this research was provided by:
RCUK | Biotechnology and Biological Sciences Research Council (B/J500446/1)
RCUK | Medical Research Council (MR/N004396/1, MR/N004396/1, MR/N004396/1)
Wellcome Trust (202831/Z/16/Z, 087736)
Article History
Received: 23 July 2021
Revised: 19 October 2022
Accepted: 28 October 2022
First Online: 2 December 2022
Competing interests
: GG was an employee of Eli Lilly & Co at the time of research and is now an employee of COMPASS Pathways. All remaining authors declare that they have no conflict of interest.